Association of JNC-8 and SPRINT Systolic Blood Pressure Levels With Cognitive Function and Related Racial Disparity
- PMID: 28828478
- PMCID: PMC5710237
- DOI: 10.1001/jamaneurol.2017.1863
Association of JNC-8 and SPRINT Systolic Blood Pressure Levels With Cognitive Function and Related Racial Disparity
Abstract
Importance: The Eighth Joint National Committee (JNC-8) recommended treating systolic blood pressure (SBP) to a target below 150 mm Hg in older adults, whereas data from the Systolic Blood Pressure Intervention Trial (SPRINT) suggested that a SBP level of lower than 120 mm Hg decreases cardiovascular event rates. Target SBP guidelines have not addressed the potential that black patients may have greater morbidity and mortality from hypertension, especially with regard to cognitive outcomes. The association of these discordant SBP targets with cognition and differences by race have not been systematically evaluated in the same population.
Objectives: To assess the long-term outcomes of the various recommended SBP levels and to determine if racial differences exist based on long-term cognitive trajectories.
Design, setting, and participants: A total of 1657 cognitively intact older adults receiving treatment for hypertension were studied from 1997 to 2007 in the Health Aging and Body Composition study. Data analysis was conducted from October 1, 2016, to January 1, 2017.
Main outcomes and measures: Cognition was assessed using the Modified Mini-Mental State Examination (3MSE) 4 times and the Digit Symbol Substitution Test (DSST) 5 times. At each visit, participants were classified as having an SBP level of 120 mm Hg or lower, 121 to 139 mm Hg, 140 to 149 mm Hg, or 150 mm Hg or higher based on the mean SBP level of 2 seated readings. Mixed models assessed the association of SBP levels with 10-year cognitive trajectories. The impact of race was tested using a race interaction term.
Results: During the 10-year study period, among the 1657 individuals (908 women and 784 black patients; mean [SE] age, 73.7 [0.1] years), there was a differential decrease in 3MSE and DSST scores by the SBP levels, with the greatest decrease in the group with SBP levels of 150 mm Hg or higher (adjusted decrease was 3.7 for 3MSE and 6.2 for DSST) and the lowest decrease in the group with SBP levels of 120 mm Hg or lower (adjusted decrease was 3.0 for 3MSE and 5.0 for DSST) (P < .001 for both). Compared with white patients, black patients had a greater difference between the higher and lower SBP levels in the decrease in cognition; adjusted differences between the group with SBP levels of 150 mm Hg or higher and the group with SBP levels of 120 mm Hg or lower were -0.05 in white patients and -0.08 in black patients for 3MSE (P = .03) and -0.07 in white patients and -0.13 in black patients for DSST (P = .05).
Conclusions and relevance: For patients 70 years of age or older receiving treatment for hypertension, a SPRINT SBP level of 120 mm Hg or lower was not associated with worsening cognitive outcome and may be superior to the JNC-8 target for cognition. Lower SBP treatment levels may result in improved cognition in black patients.
Conflict of interest statement
Figures
Comment in
-
How to Use Blood Pressure Guidelines for Best Cognitive Outcomes.JAMA Neurol. 2017 Oct 1;74(10):1172-1173. doi: 10.1001/jamaneurol.2017.1869. JAMA Neurol. 2017. PMID: 28828461 No abstract available.
Similar articles
-
Effects of intensive versus standard blood pressure control on domain-specific cognitive function: a substudy of the SPRINT randomised controlled trial.Lancet Neurol. 2020 Nov;19(11):899-907. doi: 10.1016/S1474-4422(20)30319-7. Lancet Neurol. 2020. PMID: 33098800 Free PMC article. Clinical Trial.
-
Association of Differences in Treatment Intensification, Missed Visits, and Scheduled Follow-up Interval With Racial or Ethnic Disparities in Blood Pressure Control.JAMA Cardiol. 2022 Feb 1;7(2):204-212. doi: 10.1001/jamacardio.2021.4996. JAMA Cardiol. 2022. PMID: 34878499 Free PMC article.
-
Long-Term Blood Pressure Level and Variability From Midlife to Later Life and Subsequent Cognitive Change: The ARIC Neurocognitive Study.J Am Heart Assoc. 2018 Aug 7;7(15):e009578. doi: 10.1161/JAHA.118.009578. J Am Heart Assoc. 2018. PMID: 30371241 Free PMC article.
-
Aggressive systolic blood pressure control in older subjects: benefits and risks.Postgrad Med. 2018 Mar;130(2):159-165. doi: 10.1080/00325481.2018.1433434. Epub 2018 Feb 1. Postgrad Med. 2018. PMID: 29375010 Review.
-
Target Blood Pressure in Patients with Diabetes: Asian Perspective.Yonsei Med J. 2016 Nov;57(6):1307-11. doi: 10.3349/ymj.2016.57.6.1307. Yonsei Med J. 2016. PMID: 27593856 Free PMC article. Review.
Cited by
-
Environmental, Sociocultural, Behavioral, and Biological Factors Associated with Cognitive Decline, Alzheimer's Disease, and Other Types of Dementia in Black Americans.Curr Epidemiol Rep. 2023 Dec;10(4):252-263. doi: 10.1007/s40471-023-00337-9. Epub 2023 Nov 14. Curr Epidemiol Rep. 2023. PMID: 39206249
-
Association between untreated and treated blood pressure levels and cognitive decline in community-dwelling middle-aged and older adults in China: a longitudinal study.Alzheimers Res Ther. 2024 May 10;16(1):104. doi: 10.1186/s13195-024-01467-y. Alzheimers Res Ther. 2024. PMID: 38730505 Free PMC article.
-
Characterization of African-American Super-Agers in the National Alzheimer's Coordinating Center cohort.J Am Geriatr Soc. 2024 Jul;72(7):1995-2005. doi: 10.1111/jgs.18882. Epub 2024 Mar 29. J Am Geriatr Soc. 2024. PMID: 38553838
-
Effects of intensive vs. standard blood pressure control on cognitive function: Post-hoc analysis of the STEP randomized controlled trial.Front Neurol. 2023 Feb 1;14:1042637. doi: 10.3389/fneur.2023.1042637. eCollection 2023. Front Neurol. 2023. PMID: 36816574 Free PMC article.
-
The effect of risk factors on cognition in adult cochlear implant candidates with severe to profound hearing loss.Front Psychol. 2022 Aug 16;13:837366. doi: 10.3389/fpsyg.2022.837366. eCollection 2022. Front Psychol. 2022. PMID: 36051206 Free PMC article.
References
-
- James PA, Oparil S, Carter BL, et al. . 2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-520. - PubMed
-
- Chobanian AV, Bakris GL, Black HR, et al. ; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee . Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206-1252. - PubMed
-
- Oates DJ, Berlowitz DR, Glickman ME, Silliman RA, Borzecki AM. Blood pressure and survival in the oldest old. J Am Geriatr Soc. 2007;55(3):383-388. - PubMed
-
- Skoog I, Lernfelt B, Landahl S, et al. . 15-Year longitudinal study of blood pressure and dementia. Lancet. 1996;347(9009):1141-1145. - PubMed
-
- Kivipelto M, Helkala EL, Hänninen T, et al. . Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study. Neurology. 2001;56(12):1683-1689. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
